The prevalence and incidence of medicinal cannabis on prescription in the Netherlands

European Journal of Clinical Pharmacology

Volumn 69, Issue 8, 2013, Pages 1575-1580

  Hazekamp, Arno ^a   Heerdink, Eibert R ^b,c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cannabis; Incidence; Prevalence; The Netherlands; Therapeutic use

Indexed keywords

ANALGESIC AGENT; ANTIULCER AGENT; CANNABIS; NONSTEROID ANTIINFLAMMATORY AGENT; TRANQUILIZER;

ADULT; AGED; ARTICLE; DRUG CHOICE; DRUG INDICATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANNABIDIOL; CANNABIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PHYTOTHERAPY; PREVALENCE; RETROSPECTIVE STUDIES; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 84880506108     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1503-y     Document Type: Article

References (26)

1. Office of Medicinal Cannabis (OMC), Department of Health, official website http://www.cannabisbureau.nl (accessed Sep 2012)
2. Health Canada: Canadian department of Health, Marijuana Medical Access Program: http://hc-sc.gc.ca/dhp-mps/marihuana/index-eng.php (accessed Sep 2012)
3. Americans for Safe Access (ASA). Connecticut Becomes 17th Medical Marijuana State in the Face of Ongoing Federal Intimidation. Press release of 01 June 2012. http://www.safeaccessnow.org/article.php?id=7174 (accessed Sep 2012)
4. Hazekamp A, Mueller-Vahl K, Ware M et al The medicinal use of cannabis and cannabinoids; an international cross-sectional survey on methods of intake. J Psychoactive Drugs. in press
5. Reiman AE (2007) Medical cannabis patients: patient profiles and health care utilization patterns. Complement Heal Pract Rev 12(1):31-50
6. O'Connell TJ, Bou-Matar CB (2007) Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduct J 4:16
7. Ware MA, Adams H, Guy GW (2005) The medicinal use of cannabis in the UK: results of a nationwide Survey. Int J Clin Pract 59(3):291-295
8. Page SA, Verhoef MJ, Stebbins RA et al (2003) Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 30(3):201-205
9. Ogborne AC, Smart RG, Adlaf EM (2000) Self-reported medical use of marijuana: a survey of the general population. CMAJ 162(12):1685-1686
10. Hazekamp A, Ruhaak R, Zuurman L et al (2006) Evaluation of a vaporizing device (Volcano) for the pulmonary delivery of tetrahydrocannabinol. J Pharm Sci 95(6):1308-1317
11. Hazekamp A, Bastola K, Rashidi H et al (2007) Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea. J Ethnopharm 113:85-90
12. NCSM: Dutch foundation for legal cannabis and its constituents as medicine. Survey among major health insurance companies [report in Dutch]. 2012 http://www.ncsm.nl/cfsystem/userData/pdf/1342695429-document-ncsm-vergoeding- medicinale-cannabis-2012.pdf (accessed Sep 2012)
13. Buurma H, Bouvy ML, De Smet PA et al (2008) Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther 33(1):17-23
14. WHO: World Health Organization Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc-ddd-index/ (accessed Sep 2012)
15. Bedrocan BV Supplier of medicinal cannabis, official website: http://www.bedrocan.nl (accessed Sep 2012)
16. Hazekamp A (2006) An evaluation of medicinal grade cannabis in The Netherlands. Cannabinoids 1(1):1-9
17. Lynch ME, Young J, Clark AJ (2006) A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations. J Pain Symptom Manag 32(5):497-501
18. Anichek JL, Reiman A (2012) Clinical service desires of medical cannabis patients. Harm Reduct J 9:12-17
19. Woolridge E, Barton S, Samuel J et al (2005) Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manag 29(4):358-367
20. Braitstein P, Kendall T, Chan K et al (2001) Mary-Jane and her patients: sociodemographic and clinical characteristics of HIVpositive individuals using medical marijuana and antiretroviral agents. AIDS 15(4):532-533
21. International Association for Cannabinoid Medicine (IACM). Increasing numbers of patients use cannabis for medicinal purposes. Electronic newsletter of 08 April 2012. http://blog.norml.org/2012/04/11/estimate-worldwide- population-of-lawful-medical-marijuana-patients/ (accessed Sep 2012)
22. Van der Pol P, Liebregts N, De graaf R et al (2013) Validation of self-reported cannabis dose and potency: an ecological study. Addiction, submitted
23. Narang S, Gibson D, Wasan AD et al (2008) Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain 9(3):254-264
24. Wilsey B, Marcotte T, Tsodikov A et al (2008) A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 9(6):506-521
25. Holdcroft A, Maze M, Doré C et al (2006) A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management. Anesthesiology 104(5):1040-1046
26. Zajicek JP, Hobart JC, Slade A et al (2012) Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry. Published online first: 12 July 2012. doi: 10.1136/jnnp-2012-302468